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ABSTRACT 
High performance liquid chromatography is one of the most accurate method widely used for quantitative as well as qualitative analysis of drug 
product and it is used for determining drug product stability. Stability indicating HPLC methods are used to separate various drug related 
impurities that are formed during the synthesis or manufacturing of drug product. This article discusses the strategies and issues regarding the 
development of stability indicating HPLC system for drug substance. 
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INTRODUCTION - (1,2) 
Forced degradation or stress testing is demonstrating 
specificity when developing stability-indicating methods, 
particularly when the little information is available about 
potential degradation products. These studies also provide 
information about the degradation pathways and 
degradation products that could form during storage. 
Stability testing of drug substance requires the accurate 
analytical method that quantitates the active pharmaceutical 
ingredients (API) without interfering from degradation 
products, process impurities and other potential impurities 1. 
International Conference on Harmonization (ICH) guidelines, 
the requirement of establishment of stability-indicating 
assay method (SIAM) has become more clearly mandated. 
The guidelines explain forced degradation studies under a 
variety of conditions, like pH, light, oxidation, dry heat, etc. 
and the separation of drug from degradation products. High 
performance liquid chromatography (HPLC) is the most 
accurate analytical methods widely used for the quantitative 
as well as qualitative analysis of drug product and used for 
determining drug product stability. 
STABILITY INDICATING METHOD DEVLOPMENT 
STRATERGIES: 
There is not exact formula for developing stability indicating 
analytical method. 
STEP 1: physiochemical properties of drug(4,5) 
I. Physiochemical properties of drugs are important for 
method development. 
II. Fluorescent properties chromatographic behaviour 
spectrophotometric properties, oxidation, reduction 
are useful in setting up preliminary experiments and 
helpful in stress study conditions and degradation 
mechanism. 
III. Dissociation constant and partition coefficient are 
achieve good separation by developing efficient sample 
extraction scheme and determines the optimum pH in 
the mobile phase. 
IV. Functional group or structure of analyte indicates 
potential active sites of degradation. 
STEP 2: setup preliminary HPLC conditions (5,6) 
I. Preliminary experimental conditions can be adapted 
from official or unofficial methods or literature review. 
II. Official methods are published in (USP) United States of 
pharmacopoeia. 
III. These methods are consider validated and can be used 
for stability testing. 
IV. Experimental conditions should be based on API and 
properties of drug substance. 
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V. Selection of column and mobile phase is important. 
STEP 3: Preparation of sample required for method 
development :(5) 
I. Stability indicating methods are carried out by 
stressing the API under conditions which are normally 
used for accelerated stability testing. 
II. In stability indicating method stress testing is also 
referred as force degradation and it can be used to 
provide information about degradation. 
III. Force degradation study performing the thrombolysis, 
hydrolysis and oxidation of drug. 
STEP 4: developing separation of stability indicating 
chromatographic conditions(7,8,9,10) 
I. The most common separation variables are 
temperature, solvent type mobile phase, pH etc. 
II. Initial chromatographic conditions for stability 
indicating method are new entity most important to 
degradants use in solution separated and detected. 
IMPORTANT PARAMETERS IN METHOD 
DEVLOPMENT 
I. Solvent type 
II. Mobile phase 
III. Isocratic or gradient mode 
IV. Coloumn temperature 
V. Peakpurity 
DEGRADATION STUDY IN STABILITY INDICATING 
METHOD DEVLOPMENT.(9,11) 
Forced degradation involves exposure of sample of drug 
substance or drug product. 
This experiment play important role in drug development 
process. 
Force degradation provides the following information, 
determination of degradation pathway of drug product or 
drug substance. 
Structure elucidation of degradation product produced 
thermolytic, oxidative, photolytic, hydrolytic degradation 
mechanism. 
CONCLUSION: 
Stability indicating method is analytical method which is 
used to check purity of drug substance or product which 
occurs due to stress degradation during manufacturing of 
product. 
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